1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

2.           Europe Narcolepsy Market – Key Takeaways

3.           Europe Narcolepsy Market – Market Landscape

3.1         Overview

3.2         Market Segmentation

3.2.1        Europe Narcolepsy Market – By Type

3.2.2        Europe Narcolepsy Market – By Product

3.2.3        Europe Narcolepsy Market – By Distribution Channel

3.2.4        Europe Narcolepsy Market – By Country

3.3         PEST Analysis

4.           Europe Narcolepsy Market-Key Dynamics

4.1         Key Market Drivers

4.1.1        Growing Research and Developments

4.1.2        Increasing Awareness Across the Region

4.2         Key Market Restraints

4.2.1        Challenge Related to Narcolepsy

4.3         Key Market Opportunity

4.3.1        Reimbursement For Drugs

4.4         Future Trend

4.4.1        Developments in Pharmaceutical Sector to Treat Narcolepsy

4.5         Impact Analysis Of Drivers and Restraints

5.           Narcolepsy Market – Regional Analysis

5.1         Europe Narcolepsy Market Revenue Forecasts and Analysis

5.2         Performance Of Key Players

5.2.1        Jazz Pharmaceuticals plc

5.2.2        Teva Pharmaceutical Industries Ltd.

6.           Narcolepsy Market Analysis and Forecasts to 2027 – Type

6.1         Overview

6.2         Type Market Revenue and Forecasts Analysis (US$ Mn)

6.3         Europe Narcolepsy With Cataplexy Market Revenue and Forecasts To 2027, By Type (Us$ Mn)

6.4         Narcolepsy With Cataplexy Market

6.4.1        Overview

6.4.2        Narcolepsy With Cataplexy Market Revenue and Forecast to 2027 (US$ Mn)

6.5         Narcolepsy Without Cataplexy Market

6.5.1        Overview

6.5.2        Narcolepsy Without Cataplexy Market Revenue and Forecast to 2027 (US$ Mn)

6.6         Secondary Narcolepsy Market

6.6.1        Overview

6.6.2        Secondary Narcolepsy Market Revenue and Forecast to 2027 (US$ Mn)

7.           Narcolepsy Market Analysis and Forecasts to 2027 – Product

7.1         Overview

7.2         Product Market Revenue and Forecasts Analysis (US$ Mn)

7.3         Europe Narcolespy Market Revenue and Forecasts To 2027, By Product (US$ Mn)

7.4         Central Nervous System Stimulants Market

7.4.1        Overview

7.4.2        Central Nervous System Stimulants Market Revenue and Forecast to 2027 (US$ Mn)

7.5         Sodium Oxybate Market

7.5.1        Overview

7.5.2        Sodium Oxybate Market Revenue and Forecast to 2027 (US$ Mn)

7.6         Antidepressants Market

7.6.1        Overview

7.6.2        Antidepressants Market Revenue and Forecast to 2027 (US$ Mn)

8.           Narcolepsy Market Analysis and Forecasts to 2027 – Distribution Channel

8.1         Overview

8.2         Distribution Channel Market Revenue and Forecasts Analysis (US$ Mn)

8.3         Europe Narcolespy Market Revenue and Forecasts To 2027, By End User (US$ Mn)

8.4         Hospital Pharmacies Market

8.4.1        Overview

8.4.2        Hospital Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)

8.5         Retail Pharmacies Market

8.5.1        Overview

8.5.2        Retail Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)

9.           Narcolepsy Market Revenue And Forecasts To 2027 – Geographical Analysis

9.1         Europe Narcolepsy Market

9.1.1        Overview

9.1.2        Europe Narcolepsy Market Revenue Overview, by Country (2017) (US$ Mn)

9.1.3        Europe Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.4        Europe Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.5        Europe Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.1.6        Europe Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

9.1.7        Europe Narcolepsy Market Revenue and Forecasts to 2027, By Country (%)

9.1.8        Germany Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.9        Germany Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.9.1          Germany Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.9.2          Germany Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.1.9.3          Germany Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

9.1.10     UK Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.11     UK Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.11.1       UK Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.11.2       UK Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.1.11.3       UK Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

9.1.12     France Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.13     France Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.13.1       France Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.13.2       France Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.1.13.3       France Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

9.1.14     Italy Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.15     Italy Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.15.1       Italy Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.15.2       Italy Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.1.15.3       Italy Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

9.1.16     Spain Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.17     Spain Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.17.1       Spain Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.17.2       Spain Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.1.17.3       Spain Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.        Narcolepsy Market – Industry Landscape

10.1      Overview

10.2      Comparative Company Analysis

10.3      Growth Strategies Done By The Companies In The Market, (%)

10.4      Organic Developments

10.4.1     Overview

10.5      Inorganic Developments

10.5.1     Overview

11.        Narcolepsy Market –Key Company Profiles

11.1      Teva Pharmaceutical Industries Ltd.

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Financial Overview

11.1.4     Product Portfolio

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      Jazz Pharmaceuticals Plc

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Financial Overview

11.2.4     Product Portfolio

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      Arena Pharmaceuticals, Inc.

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Financial Overview

11.3.4     Product Portfolio

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      Graymark Healthcare, Inc.

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Financial Information

11.4.4     Product Portfolio

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5      Novartis AG

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Financial Information

11.5.4     Product Portfolio

11.5.5     SWOT Analysis

11.5.6     Key Developments

11.6      Takeda Pharmaceutical Company Limited

11.6.1     Key Facts

11.6.2     Business Description

11.6.3     Financial Information

11.6.4     Product Pipeline

11.6.5     SWOT Analysis

11.6.6     Key Developments

11.7      Mylan N.V.

11.7.1     Key Facts

11.7.2     Business Description

11.7.3     Financial Overview

11.7.4     Product Portfolio

11.7.5     SWOT Analysis

11.7.6     Key Developments

11.8      Bioprojet

11.8.1     Key Facts

11.8.2     Business Description

11.8.3     Financial Overview

11.8.4     Product Portfolio

11.8.5     SWOT Analysis

11.8.6     Key Developments

11.9      Shionogi & Co., Ltd.

11.9.1     Key Facts

11.9.2     Business Description

11.9.3     Financial Overview

11.9.4     Product Portfolio

11.9.5     Product Pipeline

11.9.6     SWOT Analysis

11.9.7     Key Developments

11.10   Ligand Pharmaceuticals, Inc.

11.10.1  Key Facts

11.10.2  Business Description

11.10.3  Financial Overview

11.10.4  Product Portfolio

11.10.5  Product Pipeline

11.10.6  SWOT Analysis

11.10.7  Key Developments

12.        Appendix

12.1      About The Insight Partners

12.2      Glossary Of Terms

12.3      Methodology

12.3.1     Coverage

12.3.2     Secondary Research

12.3.3     Primary Research

LIST OF TABLES

Table 1.             Europe Narcolepsy With Cataplexy Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 2.             Europe Narcolepsy Market Revenue and Forecasts To 2027, By Product (US$ Mn)

Table 3.             Europe Narcolepsy Market Revenue and Forecasts To 2027, By End User (US$ Mn)

Table 4.             Europe Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 5.             Europe Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 6.             Europe Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 7.             Germany Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 8.             Germany Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 9.             Germany Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 10.          UK Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 11.          UK Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 12.          UK Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 13.          France Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 14.          France Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 15.          France Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 16.          Italy Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 17.          Italy Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 18.          Italy Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 19.          Spain Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 20.          Spain Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 21.          Spain Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 22.          Organic Developments Done By Companies

Table 23.          Inorganic Developments Done By Companies

Table 24.          Glossary of Terms, Narcolepsy Market

LIST OF FIGURES

Figure 1.           US Narcolepsy Market, Revenue (US$ Mn), 2018 & 2027

Figure 2.           Europe Narcolepsy Market By Type, Market Share (%), 2018

Figure 3.           Europe Narcolepsy Market By Product, Market Share (%), 2018

Figure 4.           Europe Narcolepsy Market By Distribution Channel, Market Share (%), 2018

Figure 5.           Narcolepsy Market Segmentation

Figure 6.           Europe PEST Analysis

Figure 7.           Narcolepsy Market Impact Analysis Of Drivers and Restraint

Figure 8.           Europe Narcolepsy Market – Revenue Forecasts and Analysis – 2018- 2027

Figure 9.           Type Market Analysis and Forecasts 2018 and 2027 (%)

Figure 10.        Narcolepsy With Cataplexy Market Revenue and Forecasts To 2027 (US$ Mn)

Figure 11.        Narcolepsy Without Cataplexy Market Revenue and Forecasts To 2027 (US$ Mn)

Figure 12.        Secondary Narcolepsy Market Revenue and Forecasts To 2027 (US$ Mn)

Figure 13.        Product Market Analysis and Forecasts 2018 and 2027 (%)

Figure 14.        Central Nervous System Stimulants Market Revenue and Forecasts To 2027 (US$ Mn)

Figure 15.        Sodium Oxybate Market Revenue and Forecasts To 2027 (US$ Mn)

Figure 16.        Antidepressants Market Revenue and Forecasts To 2027 (US$ Mn)

Figure 17.        Distribution Channel Market Analysis and Forecasts 2018 and 2027 (%)

Figure 18.        Hospital Pharmacies Market Revenue and Forecasts To 2027 (US$ Mn)

Figure 19.        Retail Pharmacies Market Revenue and Forecasts To 2027 (US$ Mn)

Figure 20.        Europe Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.        Europe Narcolepsy Market Revenue And Forecasts to 2027, By Country (%)

Figure 22.        Germany Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23.        UK Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24.        France Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25.        Italy Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26.        Spain Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 27.        Comparative Company Analysis

Figure 28.        Growth Strategies Done By The Companies In The Market, (%)